# The Safety and Efficacy of New-Generation BRS vs. DCB for De Novo Large Coronary Artery Lesions: A Prospective RCT

Study · id `cardio:ct-nct07162792` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07162792](<https://clinicaltrials.gov/study/NCT07162792>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07162792

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 150 participants.

## Technical summary

Registry record NCT07162792. Randomized; quadruple masking; primary purpose treatment. Start 2025-10-23 (anticipated); primary completion 2027-12-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT07162792, source copy `cardio:ctgov-nct07162792-2025-09-09`, retrieved 2026-10-26)
- Planned start: 2025-10-23 (anticipated) (ClinicalTrials.gov record NCT07162792, source copy `cardio:ctgov-nct07162792-2025-09-09`, retrieved 2026-10-26)
- Primary completion: 2027-12-30 (anticipated) (ClinicalTrials.gov record NCT07162792, source copy `cardio:ctgov-nct07162792-2025-09-09`, retrieved 2026-10-26)
- Completion: 2028-12-30 (anticipated) (ClinicalTrials.gov record NCT07162792, source copy `cardio:ctgov-nct07162792-2025-09-09`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07162792-2025-09-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Safety and Efficacy of New-Generation BRS vs. DCB for De Novo Large Coronary Artery Lesions: A Prospective RCT
- Condition: Coronary Artery Disease(CAD)
- Condition: de Novo Coronary Lesions
- Intervention (Device): bioresorbable scaffold
- Intervention (Device): drug-coated balloon
- Lead sponsor: Xuzhou Third People's Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: 2618669a14b1135408bb1075febed95c5e0a8c7c0d12225d9c3e521bebb20dfc
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
